ZWJ Investment Counsel’s Akoya BioSciences AKYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-47,975
Closed -$62.4K 246
2025
Q2
$62.4K Hold
47,975
﹤0.01% 238
2025
Q1
$66.7K Buy
47,975
+2,700
+6% +$5.91K ﹤0.01% 207
2024
Q4
$104K Hold
45,275
﹤0.01% 218
2024
Q3
$123K Sell
45,275
-1,200
-3% -$2.93K 0.01% 231
2024
Q2
$109K Buy
46,475
+1,300
+3% +$4.15K ﹤0.01% 220
2024
Q1
$212K Hold
45,175
0.01% 217
2023
Q4
$220K Sell
45,175
-100
-0.2% -$415 0.01% 184
2023
Q3
$211K Hold
45,275
0.01% 182
2023
Q2
$335K Buy
45,275
+2,025
+5% +$13.5K 0.02% 151
2023
Q1
$354K Buy
43,250
+1,250
+3% +$13.1K 0.02% 147
2022
Q4
$402K Buy
42,000
+1,500
+4% +$18.5K 0.02% 138
2022
Q3
$476K Sell
40,500
-1,500
-4% -$19.8K 0.03% 125
2022
Q2
$540K Buy
42,000
+22,000
+110% +$228K 0.03% 126
2022
Q1
$220K Buy
+20,000
New +$232K 0.01% 163

ZWJ Investment Counsel's AKYA Position: Q3 2025 in Review

ZWJ Investment Counsel sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 47,975 shares — an estimated $62.4K sold.

ZWJ Investment Counsel first reported a position in AKYA in Q1 2022 and held it in 14 quarters. The position peaked at $540K in Q2 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • ZWJ Investment Counsel reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • ZWJ Investment Counsel sold 47,975 Akoya BioSciences shares in Q3 2025, an estimated $62.4K.
  • ZWJ Investment Counsel first reported a position in Akoya BioSciences in Q1 2022 and held it in 14 quarters.
  • ZWJ Investment Counsel's Akoya BioSciences position peaked at $540K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on ZWJ Investment Counsel's 13F filing for Q3 2025, filed 15 Oct 2025.